Medicine News and Research

RSS

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Janssen announced today that the U.S. Food and Drug Administration (FDA) has approved a broader indication for the oral, once-daily medication ZYTIGA (abiraterone acetate).

10 Dec 2012

Viewpoints: Girding for a 'beloved' Medicare fight; Two views about health law's employer mandate; Doctors fear 'SGR cliff'

It's a shame that Republicans are playing into Mr. Obama's hands, negotiating in public among themselves, ... Tennessee Senator Bob Corker made the case for this strategic retreat on "Fox News Sunday," arguing that if Republicans raise tax rates as Mr. Obama wants, "the focus then shifts to entitlements and maybe it puts us in a place where we actually can do something that really saves the nation."

10 Dec 2012

Childhood obesity: an interview with Professor Clodagh O’Gorman

Childhood obesity is harder to define than adult obesity. This is because any definition of obesity relies on measurements of both height and weight, and the calculation of body mass index (BMI) based on these measurements.

10 Dec 2012

Immune dysfunction pinpointed in developmental disorder

Children with neurodevelopmental abnormalities resulting from duplication of the methyl-CpG binding protein 2 gene also have impaired T-helper-cell 1 responses, research shows.

10 Dec 2012

Don’t stretch yourself too much before cycling

Stretching immediately before starting cycling appears to impair exercise efficiency and durability, warn researchers.

10 Dec 2012

Microarray analysis ‘best test for prenatal diagnosis’

Chromosomal microarray analysis is able to identify significantly more clinically relevant information for prenatal diagnosis than is karyotyping, and is equally able to highlight aneuploidies and unbalanced rearrangements, US study findings suggest.

10 Dec 2012

Patients with sickle cell disease rely more on emergency room

Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis.

10 Dec 2012

Parents prefer hearing screenings for kids

Just yelling "turn it down" isn't enough when young people are blasting music directly into their ears via earbuds and headphones, parents say. A new poll from the University of Michigan shows parents are strongly in favor of required hearing screenings for kids all the way up to age 17.

10 Dec 2012

Pfizer joins WIN Consortium to improve personalized cancer care

Worldwide Innovative Network (WIN) in personalized cancer medicine consortium today proudly announced that Pfizer, Inc (NYSE:PFE) is the first pharmaceutical company to become a member of the consortium. Founded on the recognition that greater success can be achieved through collaboration than any organization can achieve alone, the WIN Consortium is a global network of leading academic, industry, and patient advocacy organizations working to make personalized cancer care a reality for patients worldwide.

10 Dec 2012

New study could help develop anti-inflammatory drugs with fewer side effects

10 Dec 2012

New assay test shows positive results for patients with recurrent or metastatic breast cancer

When breast cancer advances, the patient doesn't have the luxury of time. Finding the right type of chemotherapy as quickly as possible is a critical factor for the patient's success and, until now, predicting the patient's sensitivity to chemotherapy has often been a shot in the dark.

10 Dec 2012

Communication and checklists may lead to fewer surgical complications

An article published in the December issue of the Journal of the American College of Surgery found decreases in some postoperative complications when surgical teams were trained in communication and to use a procedure check list.

10 Dec 2012

Despite effective anti-viral drugs, majority of HCV patients remain untreated

Just 20 percent of people infected with the hepatitis C virus (HCV) begin the recommended treatment regimen and less than 5 percent go on to successfully overcome the virus, according to a new review in General Hospital Psychiatry.

10 Dec 2012

Project Peanut Butter and Hershey team up to reduce childhood malnutrition in rural Ghana

With funding from The Hershey Company, Project Peanut Butter announced today that it will make and distribute vitamin-enriched nutritional packets to impoverished children in rural Ghana.

10 Dec 2012

New hope for leukemia patients

Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the Perelman School of Medicine at the University of Pennsylvania

10 Dec 2012

Surgical patients with chronic psychological symptoms require psychotherapeutic treatment

In their study, the research group, headed by Privatdozent Dr. Henning Krampe, psychologist at the Charité Department of Anesthesiology and Intensive Care Medicine, Prof. Claudia Spies, Director of the Charité Department of Anesthesiology and Intensive Care Medicine and Prof. Elmar Brähler, Head of the Department of Medical Psychology and Medical Sociology at the University of Leipzig, initially recorded how many patients faced by a forthcoming operation were interested in psychotherapy sessions and to what extent this interest was associated with the increased psychological distress occurring before the operation. Finally, the scientists examined whether changes in the psychological symptoms took place during the six months following the surgery.

10 Dec 2012

Vorinostat reduces risk of graft-vs.-host disease from bone marrow transplant treatments

A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a study from researchers at the University of Michigan Comprehensive Cancer Center.

10 Dec 2012

Results from eribulin and capecitabine phase III comparison trial on metastatic breast cancer

Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival.

10 Dec 2012

Apollo launches telemedicine service in Yangon

The Apollo Group of Hospitals, one of Asia's largest healthcare providerm, formally announced the launch of its telemedicine service in Yangon on 4th December 2012.

10 Dec 2012

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Genentech, a member of the Roche Group, today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy significantly extended the lives (overall survival) of people with previously untreated HER2-positive metastatic breast cancer (mBC), compared to Herceptin, chemotherapy and placebo.

10 Dec 2012

Medicine News and Research

Janssen receives FDA approval for ZYTIGA to treat metastatic castration-resistant prostate cancer

Viewpoints: Girding for a 'beloved' Medicare fight; Two views about health law's employer mandate; Doctors fear 'SGR cliff'

Childhood obesity: an interview with Professor Clodagh O’Gorman

Immune dysfunction pinpointed in developmental disorder

Don’t stretch yourself too much before cycling

Microarray analysis ‘best test for prenatal diagnosis’

Patients with sickle cell disease rely more on emergency room

Parents prefer hearing screenings for kids

Pfizer joins WIN Consortium to improve personalized cancer care

New study could help develop anti-inflammatory drugs with fewer side effects

New assay test shows positive results for patients with recurrent or metastatic breast cancer

Communication and checklists may lead to fewer surgical complications

Despite effective anti-viral drugs, majority of HCV patients remain untreated

Project Peanut Butter and Hershey team up to reduce childhood malnutrition in rural Ghana

New hope for leukemia patients

Surgical patients with chronic psychological symptoms require psychotherapeutic treatment

Vorinostat reduces risk of graft-vs.-host disease from bone marrow transplant treatments

Results from eribulin and capecitabine phase III comparison trial on metastatic breast cancer

Apollo launches telemedicine service in Yangon

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Everything there is to know about biosimilars eBook

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News